drugset / Trial / NCT01775891
Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation
RandomizedParallel-groupOpen-labelTreatment
Summary
Investigators hypothesized that the use of Pilsicainide after radiofrequency ablation of AF could reduce the incidence of recurrence of atrial arrhythmia during follow up compared with other class IC antiarrhythmic drugs.
Timeline
- Start
- 2012-07
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | pilsicainide | Small molecule | 50 mg | Oral |
| Comparator | flecainide | Small molecule | 100 mg | Oral |
| Comparator | propafenone | Unknown | 225 mg | Oral |